Show menu

Ruxolitinib phosphate

Pharmaceutical solutions
Ruxolitinib phosphate

Introduction

Ruxolitinib is a Janus-associated kinase (JAK) inhibitor used in the treatment of myelofibrosis, atopic dermatitis and vitiligo

Technical characteristics

CAS N°: 1092939-17-7
Empirical formula: C17H21N6O4P
GMP
State: Solid
Antineoplastic and immunomodulating agents

Ruxolitinib phosphate applications

APIs

Oncology
Benjamin Schneider

Sales Manager

generics@seqens.com